A nurse is caring for a postoperative patient following a total knee replacement. Which of the following medications should the nurse anticipate the provider to prescribe to prevent the formulation of a deep vein thrombosis (DVT)?

A. Reduced fibrin split products (FSPs): In DIC, fibrin is excessively formed and subsequently broken down, leading to increased, not reduced, fibrin split products. A reduction in FSPs would not support the diagnosis and may indicate a laboratory error or absence of active clot breakdown.

B. Elevated fibrinogen: Fibrinogen is typically consumed during the coagulation process in DIC, leading to decreased levels rather than elevated. Low fibrinogen contributes to bleeding tendencies observed in patients with DIC.

C. Reduced prothrombin time (PT): In DIC, coagulation factors are depleted, resulting in a prolonged PT. A shortened PT is not consistent with consumptive coagulopathy and does not support the diagnosis.

D. Elevated D-dimer: D-dimer is a degradation product of cross-linked fibrin and is markedly elevated in DIC due to widespread clot formation and subsequent fibrinolysis. Elevated D-dimer is a key laboratory finding supporting the presence of acute DIC and correlates with active intravascular coagulation and bleeding risk.

Rationale:

A. Bradypnea: Bradypnea is not commonly associated with DIC. Respiratory rate may increase due to compensatory mechanisms from hypoxia or acidosis secondary to microvascular thrombosis, but slow breathing is not an expected finding.

B. Hypertension: DIC often leads to hypotension rather than hypertension due to systemic bleeding, fluid shifts, and potential shock. Hypertension is not a typical manifestation of this coagulopathy.

C. Bradycardia: Heart rate in DIC is usually elevated (tachycardia) as a compensatory response to bleeding, hypovolemia, or shock. Bradycardia is not a characteristic finding.

D. Epistaxis: Epistaxis (nosebleeds) is a classic manifestation of DIC due to widespread consumption of platelets and clotting factors, leading to bleeding from mucous membranes, puncture sites, and other superficial areas. It reflects the hemorrhagic phase of this disorder.